Kiora Pharmaceuticals (KPRX) Other Gross PP&E Adjustments (2016 - 2025)
Kiora Pharmaceuticals (KPRX) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$376785.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments fell 92.28% year-over-year to -$376785.0, compared with a TTM value of -$376785.0 through Sep 2025, down 92.28%, and an annual FY2024 reading of -$105946.0, up 87.92% over the prior year.
- Other Gross PP&E Adjustments was -$376785.0 for Q3 2025 at Kiora Pharmaceuticals, up from -$447127.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$87544.0 in Q3 2023 and bottomed at -$876903.0 in Q4 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$361709.4, with a median of -$300729.0 recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments plummeted 1809.67% in 2021, then skyrocketed 87.92% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$857712.0 in 2021, then soared by 31.21% to -$590061.0 in 2022, then crashed by 48.61% to -$876903.0 in 2023, then surged by 87.92% to -$105946.0 in 2024, then tumbled by 255.64% to -$376785.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for KPRX at -$376785.0 in Q3 2025, -$447127.0 in Q2 2025, and -$264639.0 in Q1 2025.